Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Entrada Therapeutics
TRDA
$281M
| $609K | ﹤0.01% |
38,107
+24,560
| +181% | +$387K |
|
3352
Electromed
ELMD
$349M
| $606K | ﹤0.01% |
+28,211
| New | +$459K |
|
3353
Kyverna Therapeutics
KYTX
$473M
| $600K | ﹤0.01% |
122,777
+4,786
| +4% | +$36.9K |
|
|
NTST
3354
NETSTREIT Corp
NTST
$2.05B
| $600K | ﹤0.01% |
+36,296
| New | +$599K |
|
3355
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $599K | ﹤0.01% |
32,110
-147,045
| -82% | -$2.33M |
|
3356
iShares Asia 50 ETF
AIA
$4.82B
| $599K | ﹤0.01% |
8,289
+114
| +1% | +$7.66K |
|
|
OPRA
3357
Opera Ltd
OPRA
$1.84B
| $597K | ﹤0.01% |
38,669
-29,973
| -44% | -$403K |
|
3358
Nature's Sunshine
NATR
$360M
| $597K | ﹤0.01% |
43,834
+997
| +2% | +$14.3K |
|
3359
WisdomTree US LargeCap Fund
EPS
$1.64B
| $597K | ﹤0.01% |
9,936
+694
| +8% | +$40.1K |
|
3360
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
| $595K | ﹤0.01% |
4,528
-33
| -0.7% | -$4.1K |
|
3361
FlexShares Quality Dividend Defensive Index Fund
QDEF
$558M
| $592K | ﹤0.01% |
8,283
+1,321
| +19% | +$90.3K |
|
3362
Gildan
GIL
$10.5B
| $586K | ﹤0.01% |
9,857
-59,116
| -86% | -$2.5M |
|
3363
Home Bancorp
HBCP
$571M
| $586K | ﹤0.01% |
13,153
| – | – |
|
3364
Alerian Energy Infrastructure ETF
ENFR
$513M
| $585K | ﹤0.01% |
20,694
-14,793
| -42% | -$406K |
|
|
ORGN
3365
DELISTED
Origin Materials
ORGN
| $578K | ﹤0.01% |
12,505
+4,062
| +48% | +$147K |
|
3366
Janus Henderson B-BBB CLO ETF
JBBB
$1.41B
| $578K | ﹤0.01% |
+11,800
| New | +$577K |
|
3367
Schwab Fundamental International Small Company Index ETF
FNDC
$3.12B
| $577K | ﹤0.01% |
15,127
+950
| +7% | +$34.4K |
|
3368
FS Bancorp
FSBW
$319M
| $575K | ﹤0.01% |
12,915
| – | – |
|
3369
BlackRock Core Bond Trust
BHK
$649M
| $573K | ﹤0.01% |
47,560
-3,892
| -8% | -$44.1K |
|
3370
UroGen Pharma
URGN
$1.94B
| $571K | ﹤0.01% |
44,965
-110
| -0.2% | -$1.63K |
|
3371
iShares MSCI USA Equal Weighted ETF
EUSA
$1.88B
| $565K | ﹤0.01% |
5,900
-564
| -9% | -$51.6K |
|
3372
BCB Bancorp
BCBP
$159M
| $561K | ﹤0.01% |
45,461
| – | – |
|
|
LEO
3373
BNY Mellon Strategic Municipals
LEO
$386M
| $560K | ﹤0.01% |
86,016
-15,193
| -15% | -$96.2K |
|
3374
Mistras Group
MG
$507M
| $559K | ﹤0.01% |
49,171
+32,496
| +195% | +$334K |
|
3375
Invesco S&P 500 BuyWrite ETF
PBP
$361M
| $559K | ﹤0.01% |
24,471
+1,836
| +8% | +$41.1K |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.